S0816 Fludeoxyglucose F 18-PET/CT Imaging
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for S0816 Fludeoxyglucose F 18-PET/CT Imaging, covering 2018-04-04 to 2018-04-04. Get the full timeline:
Most recent: Clinical Trial Update: S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma [Phase 2]